These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31010856)

  • 1. Prospective Observational Study of the Clinical Prognoses of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis.
    Kim D; Lee H; Yoon EJ; Hong JS; Shin JH; Uh Y; Shin KS; Shin JH; Kim YA; Park YS; Jeong SH
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 10-year profile of enterococcal bloodstream infections at a tertiary-care hospital in Japan.
    Suzuki H; Hase R; Otsuka Y; Hosokawa N
    J Infect Chemother; 2017 Jun; 23(6):390-393. PubMed ID: 28385565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of ampicillin or ampicillin/sulbactam versus glycopeptides in ampicillin-susceptible Enterococcus faecalis/faecium bacteremia: a 10-year retrospective cohort study.
    Seong YJ; Song JE; Lee E; Kim EJ; Heo JY; Choi YH; Kim YC
    BMC Infect Dis; 2024 Sep; 24(1):906. PubMed ID: 39223521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin-resistant Enterococcus faecalis sequence type 6 with reduced penicillin susceptibility: diagnostic and therapeutic implications.
    Guardabassi L; Larsen J; Skov R; Schønheyder HC
    J Clin Microbiol; 2010 Oct; 48(10):3820-1. PubMed ID: 20702669
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
    Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Enterococcus faecalis clinical isolates with 'penicillin-resistant, ampicillin-susceptible' phenotype as reported by Vitek-2 Compact system.
    Tan YE; Ng LS; Tan TY
    Pathology; 2014 Oct; 46(6):544-50. PubMed ID: 25158809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.
    Aamodt H; Mohn SC; Maselle S; Manji KP; Willems R; Jureen R; Langeland N; Blomberg B
    BMC Infect Dis; 2015 Feb; 15():107. PubMed ID: 25884316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis: Caution in Interpreting the Results.
    Cabrera NL; Malek AE; Aitken SL; Arias CA
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32209565
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of polymorphisms in pbp4 gene and genetic diversity in penicillin-resistant, ampicillin-susceptible Enterococcus faecalis from hospitals in different states in Brazil.
    Infante VH; Conceição N; de Oliveira AG; Darini AL
    FEMS Microbiol Lett; 2016 Apr; 363(7):. PubMed ID: 26903013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and microbiological characteristics of bloodstream infections caused by Enterococcus spp. within internal medicine wards: a two-year single-centre experience.
    Lupia T; Roberto G; Scaglione L; Shbaklo N; De Benedetto I; Scabini S; Mornese Pinna S; Curtoni A; Cavallo R; De Rosa FG; Corcione S
    Intern Emerg Med; 2022 Jun; 17(4):1129-1137. PubMed ID: 35092582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Vancomycin or Beta-Lactam Therapy in Ampicillin-Susceptible
    Fletcher JM; Kram SJ; Sarubbi CB; Anderson DJ; Kram BL
    J Pharm Pract; 2019 Aug; 32(4):375-381. PubMed ID: 29310494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, epidemiological, and microbiological characteristics of bacteremia caused by high-level gentamicin-resistant Enterococcus faecalis.
    Vigani AG; Oliveira AM; Bratfich OJ; Stucchi RS; Moretti ML
    Braz J Med Biol Res; 2008 Oct; 41(10):890-5. PubMed ID: 19030711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillin-resistant, ampicillin-susceptible Enterococcus faecalis of hospital origin: pbp4 gene polymorphism and genetic diversity.
    Conceição N; da Silva LE; Darini AL; Pitondo-Silva A; de Oliveira AG
    Infect Genet Evol; 2014 Dec; 28():289-95. PubMed ID: 25445645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ampicillin susceptibility can predict in vitro susceptibility of penicillin-resistant, ampicillin-susceptible Enterococcus faecalis Isolates to amoxicillin but not to imipenem and piperacillin.
    Conceição N; de Oliveira Cda C; da Silva LE; de Souza LR; de Oliveira AG
    J Clin Microbiol; 2012 Nov; 50(11):3729-31. PubMed ID: 22895041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
    Kak V; Donabedian SM; Zervos MJ; Kariyama R; Kumon H; Chow JW
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2545-6. PubMed ID: 10952613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with ampicillin and fluoroquinolones of human endocarditis due to high-level gentamicin-resistant enterococci.
    Tripodi MF; Locatelli A; Adinolfi LE; Andreana A; Utili R
    Eur J Clin Microbiol Infect Dis; 1998 Oct; 17(10):734-6. PubMed ID: 9865990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis.
    Beganovic M; Luther MK; Rice LB; Arias CA; Rybak MJ; LaPlante KL
    Clin Infect Dis; 2018 Jul; 67(2):303-309. PubMed ID: 29390132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study.
    Scharloo F; Cogliati Dezza F; López-Hernández I; Martínez Pérez-Crespo PM; Goikoetxea Aguirre AJ; Pérez-Rodríguez MT; Fernandez-Suarez J; León Jiménez E; Morán Rodríguez MÁ; Fernández-Natal I; Reguera Iglesias JM; Natera Kindelán C; Fariñas Álvares MC; Boix-Palop L; Lopez-Cortes LE; Rodríguez-Baño J;
    Eur J Clin Microbiol Infect Dis; 2024 Oct; 43(10):2011-2022. PubMed ID: 39112668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter evaluation of use of penicillin and ampicillin as surrogates for in vitro testing of susceptibility of enterococci to imipenem.
    Weinstein MP; Mirrett S; Kannangara S; Monahan J; Harrell LJ; Wilson AC; Reller LB
    J Clin Microbiol; 2004 Aug; 42(8):3747-51. PubMed ID: 15297525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.